DOCTOR RODNEY Trademark

Trademark Overview


On Sunday, March 3, 2024, a trademark application was filed for DOCTOR RODNEY with the United States Patent and Trademark Office. The USPTO has given the DOCTOR RODNEY trademark a serial number of 98431148. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 19, 2024. This trademark is owned by QRSTUV, LLC. The DOCTOR RODNEY trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements for humans and animals
doctor rodney

General Information


Serial Number98431148
Word MarkDOCTOR RODNEY
Filing DateSunday, March 3, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements for humans and animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQRSTUV, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressReno, NV 89504

Trademark Events


Event DateEvent Description
Sunday, March 3, 2024NEW APPLICATION ENTERED
Sunday, March 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 18, 2024ASSIGNED TO EXAMINER
Thursday, September 19, 2024NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NON-FINAL ACTION WRITTEN